Announcements and Notices - [Share Scheme]

Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.

(1) Grant Of Share Options Under The Post-Ipo
Share Option Scheme; And
 (2) Grant Of Award Shares Under The Restricted Share
Award Scheme

Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]

Annual Results Announcement
For The Year Ended December 31, 2024

Announcements and Notices - [Other - Business Update]

Voluntary Announcement -
Jskn003 Was Granted Breakthrough Therapy Designation
By The Nmpa

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Announcements and Notices - [Profit Warning / Inside Information]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Alphamab Co Ltd (9966 HK)

(1) Grant Of Share Options Under The Post-Ipo Share Option Scheme; And (2) Grant Of Award Shares Under The Restricted Share Award Scheme

Annual Results Announcement For The Year Ended December 31, 2024

Voluntary Announcement - Jskn003 Was Granted Breakthrough Therapy Designation By The Nmpa

Date Of Board Meeting

Positive Profit Alert

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)